Navigation Links
Solutia Reports Third Quarter 2009 Results
Date:10/26/2009

anged circumstances or any other occurrence.

Discontinued Operations

Solutia announced on June 1, 2009, that it sold its Nylon business to an affiliate of SK Capital Partners II, L.P. Effective with the third quarter of 2008, the company began reporting results from its Nylon segment as discontinued operations.

Corporate Profile

Solutia is a market-leading performance materials and specialty chemicals company. The company focuses on providing solutions for a better life through a range of products, including: Saflex® interlayer for laminated glass; CPFilms® aftermarket window films sold under the LLumar® brand and others; and technical specialties including the Flexsys® family of chemicals for the rubber industry, Skydrol® aviation hydraulic fluid and Therminol® heat transfer fluid. Solutia's businesses are world leaders in each of their market segments. With its headquarters in St. Louis, Missouri, USA, the company operates globally with approximately 3,100 employees in more than 60 locations. More information is available at www.Solutia.com

SOURCE Solutia Inc.


'/>"/>
SOURCE Solutia Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Solutia Reports First Quarter 2009 Results
2. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
3. Hanger Orthopedic Group, Inc. Reports an Increase of 30.4% in Earnings Per Share, to $0.30, for the Third Quarter 2009 and Raises Its 2009 Guidance
4. NuVasive Reports Third Quarter 2009 Financial Results
5. Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non-Alcoholic Steatohepatitis (NASH)
6. Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles
7. Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist
8. Peregrine Pharmaceuticals Reports Positive Results From Phase II Bavituximab Lung Cancer Trial
9. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
10. Neogen Reports 18% Increase in Net Income, 12% Increase in Revenues
11. Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Martek Biosciences Corporation (Nasdaq: MATK ) today ... fiscal year ended October 31, 2009. Revenues for the ... million in the fourth quarter of fiscal 2008. Net ... for the fourth quarter of fiscal 2009, a 5% ... share, in last year,s fourth quarter. The fourth ...
(Date:12/16/2009)... 16 /PRNewswire/ -- Capitalizing ... sciences industry and an active venture capital market, ... State Teachers Retirement Fund, Indiana University, Purdue University, ... Foundation, and Credit Suisse today announced the establishment ... capital fund of funds. ,, Organized through BioCrossroads, ...
(Date:12/16/2009)... has what scientists have been asking for! Zap-CHO is a ... and productivity of CHO cells. Developed for scientists seeking maximum ... defined and consistent recombinant CHO supplement. , ... ... Scientists working with CHO cells can now access an informational ...
(Date:12/15/2009)... one of three Department of Energy (DOE) bio-energy research ... protect its valuable intellectual property. , ... ... 2009 -- Surety, LLC , the leading provider ... that the Joint BioEnergy Institute (JBEI), one of three ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... 23 Healthcare,Technologies, Ltd. (NASDAQ: HCTL ), today ... ended September 30, 2007., Revenues for the third ... million for the corresponding quarter last year. The third ... million in the third,quarter of 2006. The net profit ...
... For more than a decade, Steve Stice has dedicated ... lives of people with degenerative diseases and debilitating injuries. ... cells from a few stem cells, could now aid ... said Stice, a University of Georgia animal science professor ...
... have long been touted as the wonder material of ... super fast computers and ultra small electronics through to ... than diamond. , Several techniques have been devised ... devices from the laboratory to the marketplace is obstructed ...
Other Biology Technology:Healthcare Technologies Reports 2007 Nine Months & Third Quarter Results 2Healthcare Technologies Reports 2007 Nine Months & Third Quarter Results 3New use for stem cells found in war on terrorism 2New use for stem cells found in war on terrorism 3Carbon nanotubes to be replaced by MoSIx nanowires in high-tech devices says new study 2
(Date:12/17/2009)... mass extinction like the previous five, each of which wiped ... planet, then North American mammals are one-fifth to one-half the ... Pennsylvania State University analysis. , Many scientists warn that the ... the result of human activity is leading to ... have occurred over the past 450 million years, the last ...
(Date:12/17/2009)... An agreement in Copenhagen to fund reduced emissions ... benefits if investments simultaneously target sites that are ... report, published today in the journal Conservation ... such as Brazil and parts of East Africa ... funding Reduced Emissions from Deforestation and forest Degradation ...
(Date:12/16/2009)... The new "Climate Knowledge and Innovation Community (Climate-KIC)" is ... Budapest. The Climate-KIC program brings together the expertise of ... a step-change in Europe,s innovation capacity to meet the ... to prepare for a new low-carbon society. In responding ... to how we produce, distribute, and consume goods, and ...
Breaking Biology News(10 mins):Study shows loss of 15-42 percent of mammals in North America 2Study shows loss of 15-42 percent of mammals in North America 3New report underlines multiple benefits but also new challenges to biodiversity-rich sites 2New report underlines multiple benefits but also new challenges to biodiversity-rich sites 3Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3Understanding how weeds are resistant to herbicides 9490 1Understanding how weeds are resistant to herbicides 9490 2Understanding how weeds are resistant to herbicides 9490 3Understanding how weeds are resistant to herbicides 9490 4Scientists Learn How Cancer Drugs Cause Hypertension 53768 1Scientists Learn How Cancer Drugs Cause Hypertension 53768 2 2410 Million in Startup Funding Approved for Maryland Health Information Exchange 53764 1 2410 Million in Startup Funding Approved for Maryland Health Information Exchange 53764 2 2410 Million in Startup Funding Approved for Maryland Health Information Exchange 53764 3
... reported in the October 16 issue of the journal ... described the suppression of this immune response in mice ... avenues for the development of drug treatments for immunosuppressive ... a virus causes suppression of the interferon response in ...
... Halloween through Valentine,s Day, chocolate helps celebrate the season. ... of the right kinds of chocolate can actually make ... Aaron and Monica Bearden, authors of CHOCOLATEA HEALTHY PASSION ... and wellness, as well as its history, culture, sensory ...
... the root of illnesses, patients have to undergo an ... the use of ionising radiation to detect the source ... also put patients at risk. , "There has been ... of patient protection that medical professionals had expected. This ...
Other Biology News:Scripps research team sheds light on immune system suppression 2Scripps research team sheds light on immune system suppression 3Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate? 2Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate? 3When the ill need protection from the cure 2When the ill need protection from the cure 3
WIF-1 (N-20)...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
...
Biology Products: